Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 319-324 , May 2012

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

  • Kenji Hashimoto, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Hiroyuki Fujimoto, M.D.

      Affiliations

    • Urology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Tsutomu Kouno, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-3542-2511; fax: +81-3-3542-3815
    • ,
  • Masahiro Koseki, M.D., M.Sc.

      Affiliations

    • Division of Biostatistics, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan
    • ,
  • Kan Yonemori, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Taizo Hirata, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Mayu Yunokawa, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Chikako Shimizu, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Noriyuki Katsumata, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Kenji Tamura, M.D., Ph.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Masashi Ando, M.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Masahiro Takeuchi, M.D., M.P.H.

      Affiliations

    • Division of Biostatistics, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan
    • ,
  • Hiroyuki Nakanishi, M.D.

      Affiliations

    • Urology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Motokiyo Komiyama, M.D.

      Affiliations

    • Urology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Tohru Nakagawa, M.D., Ph.D.

      Affiliations

    • Urology Division, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Yasuhiro Fujiwara, M.D., Ph.D.

      Affiliations

    • Breast and Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

Received 14 January 2010 ,Revised 10 February 2010 ,Accepted 10 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1078-1439(10)00049-9

doi: 10.1016/j.urolonc.2010.02.008

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 319-324 , May 2012

Article Tools

* Image Usage & Resolution